Where is Strateos located?

Strateos is headquartered in Menlo Park, United States.

How many employees does Strateos have?

As of Apr 30, 2026, the latest employee count at Strateos is 27.

Is Strateos a funded company?

Strateos is a funded company, having raised a total of $72.6M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round.

When was the latest funding round of Strateos?

Strateos' latest funding was a $***** Series B round on Jun 08, 2021, with participation from 7 investors. Its primary sector is Life Sciences Tech. In United States, the Life Sciences Tech sector has seen $2.02B in funding in 2026 to date.

Where does Strateos rank among its competitors?

Strateos ranks 38th amongst 792 active competitors, of which 81 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Owkin, which secured $33M in Mar, 2026.

Who are the top competitors of Strateos?

Strateos' top competitors include Owkin, Novotech and Strand Life Sciences. Among them, Owkin secured the most recent funding round in March, 2026.

Strateos - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of the cloud-based platform provides data-driven information for biotech research. It offers a cloud-based platform that provides data-driven information for biotech research. The platform helps in drug discovery and synthetic biology research. Its solutions include robotic cloud lab, scale on-site, and on-demand discovery biology among others.

Website: strateos.com
Social
Phone Number: +1 **********

Key Metrics

Founded Year

2019

Location

Menlo Park, United States

Stage

Series B

Total Funding

$72.6M in 4 rounds

Latest Funding Round

Series B, Jun 08, 2021, $*****

Investors

DCVC & 19 more

Ranked

38^th among 792 active competitors

Employee Count

27 as on Apr 30, 2026

Similar Companies

Owkin & 970 more

View Strateos' full profile

Strateos is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
3scan, Inc. CIN: 273646379 , United States, Active	Dec 31, 1999	-	37 (As on Dec 31, 2018)	-
AVGSF - Strateos 2021, LLC CIN: 1872579 , United States, Active		$1 - $1M (As on Jul 14, 2021)	-	-
TRANSCRIPTIC, INC. CIN: 454610289 , United States, Active	Dec 31, 1999	-	107 (As on Dec 31, 2021)	-

Strateos has raised a total funding of $72.6M over 4 rounds. Its latest funding round was a Series B round on Jun 08, 2021 for $*****. 7 investors participated in its latest round. Strateos has 20 institutional investors.

Here is the list of recent funding rounds of Strateos:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 08, 2021	3553424	Series B	3944925	3872968	8724695	2427685
Sep 15, 2019	6685859	Grant (prize money)	7582225	7699735	1939481	HHS
Jul 26, 2019	5923651	Series B	5570049	7758441	9879126	4024558

Access funding benchmarks and valuations. Sign up today!

View details of Strateos's funding rounds and investors

Strateos' Board of Directors

Strateos's board has 1 active member. Michael Collins is independent board member.

Here is the list of Strateos' board of directors:

Name	Type	Representing	Status	Duration
Michael Collins	Independent board member	-	Current	4y 10m

Strateos' employee count trend

Strateos has 27 employees as of Apr 26. Here is Strateos's employee count trend over the years:

Uncover Strateos' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Strateos include Owkin, Novotech and Strand Life Sciences. Here is the list of Top 10 competitors of Strateos, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Owkin 2016, Paris (France), Series B	Developer of agentic AI platform for biomedical research and drug development	$354M	AIC, Google Ventures & 20 others	71/100
2nd	Novotech 2002, Sydney (Australia), Acquired	Provider of clinical research services across all trial phases and therapeutic areas	$255M	Temasek, GIC & 4 others	68/100
3rd	Strand Life Sciences 2000, Bengaluru (India), Acquired	Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery	$34.9M	Biomark Capital, Quadria Capital & 92 others	65/100
4th	BGI 1999, Shenzhen (China), Public	Provider of services in genome sequencing	-	Fusion Capital, Sequoia Capital China & 15 others	64/100
5th	Concert AI 2018, Boston (United States), Series C	Provider of AI and real-world data solutions for life sciences	$300M	Sixth Street, Declaration Partners & 3 others	63/100
6th	Bioptimus 2024, Paris (France), Series A	Developer of AI foundation model to transform biological research	$76M	Cathay Innovation, Sofinnova Partners & 15 others	62/100
7th	Dotmatics 2005, Bishop s Stortford (United Kingdom), Acquired	AI powered scientific data management and workflow automation solutions	$11.3M	Scottish Equity Partners, Insight Partners ... & 4 others	62/100
8th	ONCOHOST 2017, Binyamina Giv at Ada (Israel), Series C	AI-based oncology therapy plan solution for professionals	$43M	ALIVE, OurCrowd & 5 others	61/100
9th	Sygnature Discovery 2004, Nottingham (United Kingdom), Series A	Provider of services and products for integrated drug discovery	-	Rothschild & Co, Five Arrows Principal Investments ... & 4 others	56/100
10th	Digital Science 2010, London (United Kingdom), Funding Raised	Research assistance software solutions	-	HHS	56/100
38th	Strateos 2019, Menlo Park (United States), Series B	Provider of cloud based platform provides data driven information for biotech research	$72.6M	Ally Bridge Group, Kygo & 18 others	44/100